Pharmacotherapics Advice in Guidelines for COVID-19
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference85 articles.
1. Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease;Agostini;mBio,2018
2. Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia;Al Ghamdi;BMC Infect. Dis.,2016
3. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19);Alhazzani;Intensive Care Med.,2020
4. Supportive Treatment with Tocilizumab for COVID-19: A Systematic Review;Alzghari;J. Clin. Virol.,2020
5. COVID-19: lambda interferon against viral load and hyperinflammation;Andreakos,2020
Cited by 6 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Scoping Review on COVID-19-Induced Cardiovascular Complications;COVID;2023-03-03
2. Assessment of pancreatitis associated with tocilizumab use using the United States Food and Drug Administration Adverse Event Reporting System database;Scientific Reports;2021-09-22
3. COVID-19 and gastroenteric manifestations;World Journal of Clinical Cases;2021-07-06
4. Adverse drug reactions in SARS-CoV-2 hospitalised patients: a case-series with a focus on drug–drug interactions;Internal and Emergency Medicine;2020-12-23
5. Host – virus – drug interactions as determinants of COVID-19’s phenotypes: A data-driven hypothesis;Medical Hypotheses;2020-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3